Related Experiment Video
Updated: Apr 18, 2026

Artificial Intelligence Approaches to Assessing Primary Cilia
Published on: May 1, 2021
Localizing the RPGR protein along the cilium: a new method to determine efficacies to treat RPGR mutations
R Da Costa1, E Glaus2, A Tiwari2
11] Department of Human Genetics, Faculty of Medicine and Health Sciences, University of Oldenburg, Oldenburg, Germany [2] Institute of Medical Molecular Genetics, University of Zurich, Schlieren, Switzerland.
Abstract:
Retinal dystrophies constitute a group of clinically and genetically heterogeneous diseases that cause visual impairment. As treatments are not readily available, readout assays performed in patient-derived cells can aid in the development and comparative analysis of therapeutic approaches. We describe a new method with which the localization of the retinitis pigmentosa GTPase regulator (RPGR) protein along the cilium can be used as a measure for treatment efficacy. In a patient-derived fibroblast cell line, we found that the RPGR protein is mislocalized along the ciliary axoneme. The patient carried a point mutation that leads to skipping of RPGR exon 10. We confirmed that this skipping is causative for the impaired localization of RPGR using a U7 small nuclear RNA (U7snRNA)-based antisense approach in control cells. Treatment of the patient-derived fibroblasts with therapeutic U1snRNA significantly corrected the proteins' mislocalization. In this proof of principle study, we show that detecting the RPGR protein along the cilium provides a reliable and quantifiable readout assay to evaluate the efficacy of therapies intended to correct or silence RPGR gene mutations. This method opens the possibility to compare different therapeutic agents, and thus facilitate the identification of treatment options for the clinically and molecularly complex RPGR-associated diseases.
Insights
Researchers developed a new assay to measure treatment efficacy for retinal dystrophies. This method tracks the retinitis pigmentosa GTPase regulator (RPGR) protein
Area of Science:
- Ophthalmology
- Genetics
- Cell Biology
Background:
- Retinal dystrophies are genetic disorders causing vision loss.
- Current treatments are limited, necessitating effective therapeutic development tools.
- Patient-derived cells offer a model for studying disease mechanisms and testing therapies.
Purpose of the Study:
- To establish a novel readout assay for evaluating therapeutic efficacy in RPGR-associated retinal dystrophies.
- To demonstrate the utility of RPGR protein localization within cilia as a quantifiable treatment response indicator.
- To facilitate the development and comparison of therapies for complex genetic eye diseases.
Main Methods:
- Utilized patient-derived fibroblasts with a specific RPGR mutation (exon 10 skipping).
- Employed U7 small nuclear RNA (U7snRNA) antisense technology to confirm mutation-induced RPGR mislocalization.
- Applied therapeutic U1snRNA to correct RPGR localization in patient cells.
Main Results:
- Identified mislocalization of the RPGR protein along the ciliary axoneme in patient-derived cells.
- Confirmed that exon 10 skipping in RPGR causes this impaired protein localization.
- Demonstrated significant correction of RPGR mislocalization following U1snRNA treatment.
Conclusions:
- RPGR protein localization within cilia serves as a reliable and quantifiable assay for treatment efficacy.
- This method enables comparative analysis of therapeutic agents for RPGR-related disorders.
- The assay facilitates the identification of effective treatments for complex genetic retinal diseases.
More Related Videos
05:15Author Spotlight: Understanding the Ultrastructural Basis of Retinal Synaptic Connectivity and Neurotransmitter Localization in Mice
Published on: July 12, 2024
09:53Volumetric Imaging and Analysis of Primary Cilia in Musculoskeletal Tissue using the ARL13B-CENTRIN-2 Mouse Model
Published on: March 28, 2025
Related Concept Videos
Directing Proteins to the Rough Endoplasmic Reticulum
Microtubules in Signaling
Cell Polarization by Rho Proteins
Rab Proteins
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
GPI Anchoring of Proteins in the ER Membrane
GPI-anchor structure
A sequence of 11 enzymatic reactions results in the synthesis of the complete GPI anchor consisting of a hydrophobic and a hydrophilic portion. The hydrophobic portion comprises phosphatidylinositol, while the hydrophilic part comprises polar groups like phosphoethanolamine,...